CBLL2 Gene: Structure, Function, and Disease Relevance

A comprehensive overview of the CBLL2 gene, including its genomic context, expression patterns, and potential implications in disease.

Gene Information Card

Symbol CBLL2
Full Name Cbl proto-oncogene like 2
Gene Type protein coding
Chromosomal Location 1p36.33
NCBI Gene ID 158886 ncbi.nlm.nih.gov/gene/158886
Ensembl ID ENSG00000221988
UniProt ID Q6ZNK6
OMIM ID 617543
HGNC ID 28262
Aliases DKFZp686K23112, FLJ46365

Description

CBLL2 (Cbl proto-oncogene like 2) is a protein-coding gene located on the short arm of chromosome 1 (1p36.33). It encodes a protein that shares similarity with the Cbl family of E3 ubiquitin ligases, which are involved in protein ubiquitination and degradation. The exact function of CBLL2 is not fully characterized, but it is predicted to play a role in cellular signaling and protein turnover. Expression data suggest it is present in various tissues, with notable levels in the testis and certain brain regions. Mutations and altered expression of CBLL2 have been implicated in some cancers, though its clinical significance is still under investigation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Altered expression and potential mutations may affect ubiquitin ligase activity, impacting cell proliferation and survival. COSMIC database lists somatic mutations in CBLL2 across multiple cancer types, though functional validation is limited.
Neurodevelopmental disorders Predicted involvement in neuronal signaling; however, no direct evidence is established. No curated disease association in OMIM or ClinVar as of current data.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.2 Medium
Brain (cerebellum) 8.5 Low
Thyroid 6.3 Low
Lung 4.1 Low
Liver 2.0 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 5.0 Low expression
K562 3.2 Low expression
MCF7 2.5 Low expression
A549 1.8 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234A>G (p.Thr412Ala) Missense 0.01% (global) Unknown; predicted benign by in silico tools.
c.567C>T (p.Pro189Leu) Missense 0.005% Unknown; may affect protein stability.
c.890_891del (p.Glu297fs) Frameshift Rare Predicted loss of function; likely deleterious.
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations leading to premature stop codons are predicted to result in loss of function, potentially impairing ubiquitin ligase activity.

Gain of Function (GOF)

No evidence for gain-of-function mutations in CBLL2.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• ubiquitin-protein transferase activity • metal ion binding
• zinc ion binding • protein ubiquitination
• signal transduction

Pathways

Ubiquitin-mediated proteolysis
EGFR signaling pathway (predicted)

Protein Summary

The CBLL2 protein is a putative E3 ubiquitin ligase, containing a RING finger domain and a Cbl-type phosphotyrosine-binding domain. It is predicted to participate in the ubiquitination of target proteins, marking them for degradation via the proteasome. Its expression in testis suggests a possible role in spermatogenesis, while its presence in brain regions hints at neuronal functions. However, the full repertoire of substrates and biological processes remains to be elucidated.

Related Products

Product name Cat.No. Species Gene ID
CBLL2 Knockout HEK293 Cell Line EDJ-KQ12744 Human 158506 Details Get a Quote
CBLL2 Knockout HeLa Cell Line EDJ-KQ58786 Human 158506 Details Get a Quote
CBLL2 Knockout A-549 Cell Line EDJ-KQ67269 Human 158506 Details Get a Quote
CBLL2 Knockout HCT 116 Cell Line EDJ-KQ75668 Human 158506 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: